TAKAO OHNUMA, MD
Osteopathic Medicine in New York, NY

License number

New York 102828

Personal information

See more information about TAKAO OHNUMA at radaris.com

Name

Address

Phone

Takao Y Ohnuma, age 52

11 Paxford Ln, Scarsdale, NY 10583

(914) 472-3463

Takao Ohnuma, age 92

72 Clarendon Rd, Scarsdale, NY 10583

Takao Ohnuma

7 Kaateskill Pl, Scarsdale, NY 10583

Takao Y Ohnuma, age 92

19 104Th St, New York, NY 10025

(212) 222-1467

Organization information

See more information about TAKAO OHNUMA at bizstanding.com

Takao Ohnuma MD

1190 5 Ave, New York, NY 10029

Industry:

Oncology, Internist

Phone:

(212) 241-6756 (Phone)

Description:

There are 14 doctors at this site. Surgery is not performed at this site.

Takao Ohnuma

Professional information

See more information about TAKAO OHNUMA at trustoria.com

Takao Ohnuma, New York NY

Specialties:

Internist, Oncologist

Address:

1470 Madison Avenue, New York, NY 10029

Education:

Medical School - Tohoku University Medical School, MD
Coler Memorial Hospital (Residency - Internal Medicine)
Lincoln Hospital (Residency - Rotating)
Roswell Park Memorial Institute (Residency - Internal Medicine)
Roswell Park Memorial Institute (Fellowship - Medical Oncology)

Languages:

English

Awards and Publications:

Wang FS, Kobayashi H, Liang KW, Holland JF, Ohnuma T. Retrovirus-mediated anti-MDR1 ribozymes fully restores chemosensitivity of P-glycoprotein-expressing human lymphoma cells. Hum Gene Ther 1999; 10: 1185-1195., Halatsch ME, Botefur IC, Schmidt U, Holland JF, Ohnuma T. Marked inhibition of glioblastoma target cell tumorigenicity in vitro by retrovirus-mediated transfer of a hairpin ribozyme against deletion-mutant epidermal growth factor receptor messenger RNA. J Neurosurg 2000; 92: 297-305., Plasse T, Ohnuma T, Brooks S, Saponara E, Holland J, Biller H. Bleomycin infusion followed by cyclophosphamide, methotrexate and fluorouracil in advanced squamous carcinoma of the head and neck. Cancer 1984; 53: 841-843., Kobayashi H, Takemura Y, Holland JF, Ohnuma T. Vincristine saturation of cellular binding sites and its cytotoxic activity in human lymphoblastic leukemia cells: Mechanism of inoculum effect. Biochem Pharmacol 1998; 55: 1229-1234., Kobayashi H, Takemura Y, Wang FS, Oka T, Ohnuma T. Retrovirus-mediated transfer of anti-MDR1 hammerhead ribozymes into multidrug-resistant human leukemia cells: Screening for effective target sites. Int J Cancer 1999; 81: 944-950.